DS-8895a

DS-8895a · Ludwig Institute for Cancer Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-8895a, covering 2019-03-01 to 2019-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers [Phase 1]